PFA
GILD icon

Peak Financial Advisors’s Gilead Sciences GILD Stock Holding History

Peak Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,040
Closed -$677K – 95
2025
Q1 		$677K Buy
6,040
+100
+2% +$10.3K 0.34% 50
2024
Q4 		$549K Sell
5,940
-91
-2% -$8.19K 0.29% 52
2024
Q3 		$506K Sell
6,031
-14
-0.2% -$1.07K 0.26% 54
2024
Q2 		$415K Buy
6,045
+459
+8% +$30.6K 0.24% 59
2024
Q1 		$409K Buy
5,586
+425
+8% +$32.7K 0.25% 57
2023
Q4 		$418K Buy
5,161
+1,338
+35% +$104K 0.28% 56
2023
Q3 		$286K Buy
3,823
+366
+11% +$28.2K 0.31% 42
2023
Q2 		$266K Buy
3,457
+623
+22% +$49.7K 0.21% 61
2023
Q1 		$235K Buy
2,834
+145
+5% +$12K 0.2% 56
2022
Q4 		$231K Sell
2,689
-1,637
-38% -$130K 0.21% 55
2022
Q3 		$267K Sell
4,326
-993
-19% -$62.6K 0.33% 51
2022
Q2 		$329K Buy
+5,319
New +$329K 0.33% 55

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Peak Financial Advisors's GILD Position: Q2 2025 in Review

Peak Financial Advisors sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 6,040 shares — an estimated $677K sold.

Peak Financial Advisors first reported a position in GILD in Q2 2022 and held it in 12 quarters. The position peaked at $677K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Peak Financial Advisors reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Peak Financial Advisors sold 6,040 Gilead Sciences shares in Q2 2025, an estimated $677K.
  • Peak Financial Advisors first reported a position in Gilead Sciences in Q2 2022 and held it in 12 quarters.
  • Peak Financial Advisors's Gilead Sciences position peaked at $677K in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Peak Financial Advisors's 13F filing for Q2 2025, filed 7 Jul 2025.